US Pharma MarketingPre-launch efforts linked to lasting drug awareness edge: report
Pre-launch efforts linked to lasting drug awareness edge: report is a pharma and life sciences industry update from FiercePharma. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Cancer treatments with high levels of physician awareness at launch maintain their advantage over drugs that are yet to gain widespread recognition when they come to market, a ZoomRx analysis found.
Source: FiercePharma